Vaccinex Inc (VCNX)

$1.01 -0.05 (-4.72%)
Market Cap 2.76M
Revenue (ttm) 570,000.00
Net Income (ttm) -20.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,552.63%
Debt to Equity Ratio -0.03
Volume 47,806
Avg Vol 128,437
Day's Range N/A - N/A
Shares Out 2.60M
Stochastic %K 7%
Beta 1.10
Analysts Strong Buy
Price Target $7.00

Company Profile

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer's disease and has completed phase 2 study for the treatment of Huntington's disease; Pepin...

Industry: Biotechnology
Sector: Healthcare
Phone: 585 271 2700
Fax: 585 271 2765
Address:
1895 Mount Hope Avenue, Rochester, United States
LionNoRichy
LionNoRichy Sep. 11 at 2:05 PM
$VCNX XD you can have my shares for $5 each I won't complain
0 · Reply
Javivi33
Javivi33 Sep. 10 at 5:54 AM
$VCNX Almost 2 months without any publication in LinkedIn. And that with 10 activmab contracts going on. Their plan for dissapearing is working 150%.
1 · Reply
Javivi33
Javivi33 Sep. 8 at 8:04 PM
$VCNX The value of pepinemab and activmab linked to the 2.6 million shares directly, is from 1 billion to 2.5 billion dollar. The end.
3 · Reply
St0ckPwn
St0ckPwn Sep. 7 at 3:05 AM
$VCNX how do you say all those things below in PR’s and still get delisted? I still think there’s something here, however the timeline of when that is only God knows. You don’t just have 50 + % insider ownership then disappear. Clearly they didn’t care about staying listed or using the public as funding in the future because they could’ve said anything during that hearing to stay listed Otherwise they may have gambled too hard on the counsel decision and they turned out to be assholes
1 · Reply
St0ckPwn
St0ckPwn Sep. 7 at 2:55 AM
$VCNX March 7 - “The Company plans to continue to focus on development of its lead product, pepinemab, to treat Alzheimer’s disease and cancer through partnerships, grants and other financing avenues.” Nov 7 - “Vaccinex has signed agreements to provide Charles River Labs, OmniAb, Adimab and other undisclosed strategic partners The financial terms of the agreements are undisclosed.” October 31 - “The Company plans to continue partnering discussions for continued development of pepinemab in AD, HD and potentially other neurodegenerative diseases.” August 14 - “The Company believes that it has compiled compelling early phase evidence and that it is well-positioned to enter into a major partnership for continued development without a need for it to perform additional proof of concept studies. “ July 31 - “Vaccinex is actively exploring the potential for continuing late stage development in AD together with a major pharmaceutical partner.” There’s just no way lol
0 · Reply
Javivi33
Javivi33 Sep. 5 at 9:12 PM
$VCNX Has somebody been able to buy some shares in the last weeks?..even 100 , I don´t care.
2 · Reply
St0ckPwn
St0ckPwn Sep. 5 at 4:02 PM
$VCNX just cease operations already. How is it remotely possible they’re still running
2 · Reply
chris_stocks
chris_stocks Sep. 5 at 12:40 PM
$VCNX Can this get delisted from the OTC? lol
1 · Reply
St0ckPwn
St0ckPwn Sep. 3 at 7:32 PM
$PPBT - Consensi Failed. - NT-219 Failed. - CM-24 Failed. - CAPTN-3 will fail due to lack of funds. - Hired Fabien and failed - Hired Shai Lankry as a last effort and failed. - Failed at meeting F-3 requirements and will also fail to raise anything with their recent F-1. - Gil and Isaac. Failures. Is the biotech space this bad or did major incompetency happen internally? This is going to become like $VCNX, but the only difference is that VCNX had a majority holding by insiders before they delisted. May God help and cure the people that these drugs should’ve done
2 · Reply
Tyjelly
Tyjelly Sep. 3 at 2:19 PM
$VCNX whos buying
4 · Reply
Latest News on VCNX
No data available.
LionNoRichy
LionNoRichy Sep. 11 at 2:05 PM
$VCNX XD you can have my shares for $5 each I won't complain
0 · Reply
Javivi33
Javivi33 Sep. 10 at 5:54 AM
$VCNX Almost 2 months without any publication in LinkedIn. And that with 10 activmab contracts going on. Their plan for dissapearing is working 150%.
1 · Reply
Javivi33
Javivi33 Sep. 8 at 8:04 PM
$VCNX The value of pepinemab and activmab linked to the 2.6 million shares directly, is from 1 billion to 2.5 billion dollar. The end.
3 · Reply
St0ckPwn
St0ckPwn Sep. 7 at 3:05 AM
$VCNX how do you say all those things below in PR’s and still get delisted? I still think there’s something here, however the timeline of when that is only God knows. You don’t just have 50 + % insider ownership then disappear. Clearly they didn’t care about staying listed or using the public as funding in the future because they could’ve said anything during that hearing to stay listed Otherwise they may have gambled too hard on the counsel decision and they turned out to be assholes
1 · Reply
St0ckPwn
St0ckPwn Sep. 7 at 2:55 AM
$VCNX March 7 - “The Company plans to continue to focus on development of its lead product, pepinemab, to treat Alzheimer’s disease and cancer through partnerships, grants and other financing avenues.” Nov 7 - “Vaccinex has signed agreements to provide Charles River Labs, OmniAb, Adimab and other undisclosed strategic partners The financial terms of the agreements are undisclosed.” October 31 - “The Company plans to continue partnering discussions for continued development of pepinemab in AD, HD and potentially other neurodegenerative diseases.” August 14 - “The Company believes that it has compiled compelling early phase evidence and that it is well-positioned to enter into a major partnership for continued development without a need for it to perform additional proof of concept studies. “ July 31 - “Vaccinex is actively exploring the potential for continuing late stage development in AD together with a major pharmaceutical partner.” There’s just no way lol
0 · Reply
Javivi33
Javivi33 Sep. 5 at 9:12 PM
$VCNX Has somebody been able to buy some shares in the last weeks?..even 100 , I don´t care.
2 · Reply
St0ckPwn
St0ckPwn Sep. 5 at 4:02 PM
$VCNX just cease operations already. How is it remotely possible they’re still running
2 · Reply
chris_stocks
chris_stocks Sep. 5 at 12:40 PM
$VCNX Can this get delisted from the OTC? lol
1 · Reply
St0ckPwn
St0ckPwn Sep. 3 at 7:32 PM
$PPBT - Consensi Failed. - NT-219 Failed. - CM-24 Failed. - CAPTN-3 will fail due to lack of funds. - Hired Fabien and failed - Hired Shai Lankry as a last effort and failed. - Failed at meeting F-3 requirements and will also fail to raise anything with their recent F-1. - Gil and Isaac. Failures. Is the biotech space this bad or did major incompetency happen internally? This is going to become like $VCNX, but the only difference is that VCNX had a majority holding by insiders before they delisted. May God help and cure the people that these drugs should’ve done
2 · Reply
Tyjelly
Tyjelly Sep. 3 at 2:19 PM
$VCNX whos buying
4 · Reply
LionNoRichy
LionNoRichy Sep. 3 at 1:46 PM
$VCNX 🤣 100% gain is nuts hah
1 · Reply
St0ckPwn
St0ckPwn Sep. 2 at 7:20 PM
$VCNX completely dead lol
1 · Reply
justfacts1
justfacts1 Aug. 31 at 9:49 PM
$VCNX Open Positions Regulatory Affairs Associate, Regulatory Affairs and Quality Systems –> We welcome receiving resumes from highly qualified candidates with extensive background and experience in biologics research and biopharmaceutical development. Please email a cover letter and CV/resume to [email protected]. Please Note: Due to the high volume of interest we may not respond to your inquiry. Please check back often for new employment opportunities!
2 · Reply
justfacts1
justfacts1 Aug. 29 at 4:00 PM
$VCNX javiv33 is an example of delusional, he thinks its very nice nobody else selling while the stock lost 99% of its value!
1 · Reply
Javivi33
Javivi33 Aug. 28 at 4:41 PM
$VCNX Very nice, nobody else is selling. They can keep paying the market maker, I think he is tempting the nothingness.
1 · Reply
Javivi33
Javivi33 Aug. 26 at 8:52 PM
$VCNX Another day of 0...already almost 2 weeks..0 shares recovered.
1 · Reply
St0ckPwn
St0ckPwn Aug. 26 at 2:02 PM
$VCNX the worst part of this is that they’re allowed to not notify us of anything. So for all we know this could take another year and that’s even if they had a deal under wraps before delisting What’s the point of investing in bios if all these people do is scam their shareholders and siphon every dollar then tell you to screw off in the end. It used to be high risk high reward but in the last 5 years it’s been high risk no reward you might as well burn your money at the casino
3 · Reply
justfacts1
justfacts1 Aug. 25 at 9:32 PM
$VCNX whats the point of keeping it running? If they don’t have the money to advance?!is it because no one thinks its worth buying?!
1 · Reply
Javivi33
Javivi33 Aug. 25 at 8:35 PM
$VCNX These sales with 26 decimals are they selling to themselves, so today again 0 shares recovered. Good luck tomorrow!
0 · Reply
Javivi33
Javivi33 Aug. 25 at 5:51 PM
$VCNX Wow Friedberg ,máster movement, 0.42$ wow, I am preparing to sell all my shares for the third temple.
0 · Reply
LionNoRichy
LionNoRichy Aug. 25 at 1:20 PM
$VCNX frankly speaking imagine selling this for 80-90-95 loss xd just hold
2 · Reply
Javivi33
Javivi33 Aug. 24 at 7:16 PM
$VCNX
0 · Reply